Pediatric Clinical Trials Market Analysis, Size, Growth, Share, Trend, Outlook & Forecast 20222030
Pediatric Clinical Trials Market Growth & Trends
The global pediatric clinical trials market size is expected to reach USD 23.6 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 5.1% over the forecast period. The market is growing on account of the rise in the number of pediatric clinical studies globally. As per the BMC journal, between January 2008 and December 2010, 7,029 pediatric clinical trials were registered. Whereas, between January 2017 and December 2019, the number of registered pediatric clinical trials was 11,738, which certainly reflects a significant surge in the total number of trials across the industry. The treatment options for COVID 19 pediatric patients were limited at the start of the pandemic, owing to which, in May 2020, FDA granted an Emergency Use Authorization (EUA) for Veklury (remdesivir), which could be used for the treatment of COVID 19 in adults and children.
Similarly, Convalescent plasma was also granted an EUA from the FDA for the treatment of children and adults with COVID 19. Such actions by the regulatory agencies are likely to promote the demand for pediatric clinical trials. Furthermore, increasing efforts by several government bodies to support the clinical research pertaining to pediatric diseases has further supported the market growth. For instance, in March 2022, the National Cancer Institute launched the Molecular Characterization Initiative for pediatric tumors. The Initiative is offered through NCI’s Childhood Cancer Data Initiative, which was formed to
promote data sharing and collection of new data among researchers who study pediatric oncology.
Browse full report with Table of Content (PDF with All Related Graph and Chart)
@: https://www.grandviewresearch.com/industry analysis/pediatric clinical trials market report
For instance, according to the U.S. CDC, over 26.9 million in the U.S. were diagnosed with diabetes in 2018, which included 210,000 children and adolescents younger than age 20 or 25 years. Commercially, COVID19 vaccines were majorly focused on immunizing adults aged 18 years and above, this created a high risk of disease among children below the age of 18 years. The ClinicalTrial.GOV reports that as on 4th May 2022, over 1000 studies were in the active stage for treating and diagnosing COVID-19 for pediatric patients. The burden of COVID 19 among the kids is likely to promote the demand for COVID 19 vaccine trials for pediatrics from 2021.
Pediatric Clinical Trials Market Report Highlights
The observational segment is expected to witness a considerable growth rate over the forecast period. These studies are done to investigate rare outcomes of the treatment and to detect unusual adverse effects. Such factors are driving the demand for observational studies in pediatrics
The Phase II segment accounted for the largest share in 2021. Phase II studies consist of a high number of pediatric subjects; moreover, studies in this phase are more complex than that in other phases. Such factors are contributed to the segment's high share
Based on therapeutic area, the oncology segment accounted for the largest share in 2021, after the others segment, owing to the high burden of cancer among the pediatrics, thus contributing to the demand for clinical studies
Asia Pacific is projected to witness the fastest CAGR during the forecast years owing to the high population of the region, which contributes to the demand for new treatments
Pediatric Clinical Trials Market Segmentation
GrandViewResearchhassegmentedtheglobalpediatricclinicaltrialsmarketonthe basisofphase,studydesign,therapeuticareas,andregion:
Pediatric Clinical Trials Phase Outlook (Revenue, USD Million, 2018 2030)
PhaseI
PhaseII
PhaseIII
PhaseIV
Pediatric Clinical Trials Study Design Outlook (Revenue, USD Million, 2018 2030)
TreatmentStudies
ObservationalStudies
For Requesting a Sample Copy of This Report, Please Visit @ https://www.grandviewresearch.com/industry analysis/pediatric clinical trials market report/request/rs1
Pediatric Clinical Trials Therapeutic Areas Outlook (Revenue, USD Million, 2018 2030)
InfectiousDiseases
Oncology
Autoimmune/InflammatoryDiseases
RespiratoryDisorders
MentalHealthDisorders
Others
Pediatric Clinical Trials Regional Outlook (Revenue, USD Million, 2018 - 2030)
NorthAmerica
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Pacific
India
o Japan
China
o Thailand
SouthKorea
LatinAmerica
o Brazil
Mexico
o Argentina
Colombia
MiddleEast&Africa
o SouthAfrica
o SaudiArabia
o UAE
List of Key Players of Pediatric Clinical Trials Market
ICONplc
SyneosHealth
Medpace,Inc.
PPDInc.
PremierResearch
LabCorpDrugDevelopment
QPSHoldings.
PfizerInc.
TheEmmesCompany,LLC
IQVIAInc.
For Requesting a Free Consultation https://www.grandviewresearch.com/request free consultation/452825/rfc
Why Purchase this Report?
A strong research methodology was followed to collect data for the report. The data collected in this way are subjected to several quality checks to provide the best quality.
The report provides a holistic view of the competitive Pediatric Clinical Trials Market
The latest product launches, along with technological changes and developments, are included in the report.
The data analysis in the report will help you understand the Pediatric Clinical Trials Market dynamics projected from 2022 2030
The Report has a vast data store, so it can accommodate your custom needs as well.
Highlights Points of the Market:
The latest information on how the market is evolving to formulate their sales and marketing strategies. This Market report has been created to provide its readers with up to date information and analysis to uncover emerging opportunities for growth.
The market report covers the key challenges, competitive landscape, and demographic analysis that can help companies get insight into the country specific variations.
The analysts also emphasize on the key trends and the future opportunities that can be explored in the region than can help companies in revenue expansion.
To gain competitive intelligence about leading companies with information about their market share and growth rates.
Know More Related Report:
Biodegradable Plastic Packaging Market Size, Share & Trends Analysis Report By Ingredient, By Source, By Application, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2019 To 2027
Top And Emerging Biofuels Market Size, Share & Trends Analysis Report By Application, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2019 To 2025
Bio based Itaconic Acid Market Size, Share & Trends Analysis Report By Application, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2019 To 2025
Rhamnolipids Market Analysis, Market Size, Application, Analysis, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2015 To 2022
About Grand View Research
Grand View Research is a full time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.